174 related articles for article (PubMed ID: 21084661)
1. Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes.
Parsons RF; Vivek K; Rostami SY; Zekavat G; Ziaie SM; Luo Y; Koeberlein B; Redfield RR; Cancro MP; Naji A; Noorchashm H
J Immunol; 2011 Jan; 186(1):614-20. PubMed ID: 21084661
[TBL] [Abstract][Full Text] [Related]
2. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance.
Parsons RF; Redfield RR; Rodriguez E; Mustafa MM; Vivek K; Murayama M; Naji A; Noorchashm H
Semin Immunol; 2012 Apr; 24(2):109-14. PubMed ID: 21978627
[TBL] [Abstract][Full Text] [Related]
3. Induction of central tolerance by mature T cells.
Tian C; Bagley J; Forman D; Iacomini J
J Immunol; 2004 Dec; 173(12):7217-22. PubMed ID: 15585843
[TBL] [Abstract][Full Text] [Related]
4. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
5. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
6. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.
Umemura A; Morita H; Li XC; Tahan S; Monaco AP; Maki T
J Immunol; 2001 Sep; 167(6):3043-8. PubMed ID: 11544287
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
9. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
10. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
[TBL] [Abstract][Full Text] [Related]
11. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
12. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
[TBL] [Abstract][Full Text] [Related]
13. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
[TBL] [Abstract][Full Text] [Related]
15. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
[TBL] [Abstract][Full Text] [Related]
16. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.
Burns AM; Chong AS
J Immunol; 2011 Jan; 186(1):214-21. PubMed ID: 21135169
[TBL] [Abstract][Full Text] [Related]
17. Long-term control of alloreactive B cell responses by the suppression of T cell help.
Li Y; Ma L; Yin D; Shen J; Chong AS
J Immunol; 2008 May; 180(9):6077-84. PubMed ID: 18424729
[TBL] [Abstract][Full Text] [Related]
18. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
[TBL] [Abstract][Full Text] [Related]
19. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
20. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3038. PubMed ID: 30728823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
